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ABSTRACT
Using immunoblotting and densitometer techniques,
we followed the levels of IgE and IgG4 antibodies
to Dermatophagoides farinae antigen in the sera of
12 asthmatic children during immunotherapy,
repeated injections of house dust extract, for 2 years.
The symptoms of asthma were reduced or disap-
peared by the 6th month after starting immunotherapy
in 12 children. Two years later, RAST scores to house
dust and D. farinae in each child were still 4 or 5. The
levels of IgE antibodies to Der fII in all cases did not
change drastically. IgE antibodies to higher molecular
weight antigens (Der fl, fill, flV etc.) developed in some
cases, suggesting that repeated injections of crude
extract tended to induce IgE antibodies to alternative
molecules in patients. The IgG4 antibody to Der fII
increased in 10 cases, while that to Der fI increased in
three of 12 cases, indicating that production of IgG4
antibodies to mite antigens started and expanded with
repeated injections of house dust extract. The amount
of induced IgG4 antibodies to Der fI and Der fII was not
enough to inhibit the immunoblot reaction of IgE anti-
bodies to these molecules.
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INTRODUCTION
Allergen immunotherapy, repeated injections of allergen
to patients, has been practised for more than 80 veers.'
The efficacy of immunotherapy has been reported by
double blind tests,2-5 although its mechanism has not
been clarified as yet. A possible role has been suggested
in which repeated injections of allergen induce blocking
antibodies that compete for epitope sites on the allergen
molecule with IgE antibodies on the mast cell surface. 6,7
During house dust extract immunotherapy for patients
with nasal allergies or bronchial asthma due to house
dust mites, levels of IgE and IgG antibodies have been
measured by radio-allergosorbent test (RAST) and
enzyme-linked immunosorbent assay (ELISA) using crude
mite extract as an antigen. In most patients, IgE antibody
levels to crude mite extract do not change, although IgG
antibody levels, in particular IgG4, increase during
immunotherapy. Several reports have indicated that the
IgG4 subclass works as a blocking antibody.s-12
If sufficient IgG antibody to the mite allergen molecule
is induced, IgE antibody levels to the molecule should be
reduced, because competition for the epitope sites on the
molecule will occur between IgE and IgG antibodies.
There are two possible reasons to explain why IgE levels
to crude mite antigen in in vitro tests do not change
during immunotherapy. One is that the levels of blocking
antibody are not high enough to inhibit the reaction
between IgE antibody and the antigen under in vitro con-
ditions. The other is that IgE antibodies to alternative
molecules of mite antigen are induced by repeated injec-
tions of crude house dust extract.
Mite antigen consists of numerous molecules inducing
IgE and IgG13,14 and not all people may react to these
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molecules in the same manner. It is necessary to follow
IgE and IgG antibody levels to each molecule of mite
antigen during immunotherapy. Immunoblot analysis
demonstrates numerous allergens in mite extract and
helps us to recognize the polymorphism of humans in the
recognition of mite antigen. Of these allergens, Der fl
and Der pi (24 kDa) as well as Der fII and Der pll
(15 kDa) are considered major allergens. 15,16 More than
50% of atopic sera to mite extract react with these major
allergens. In the present report we used immunoblotting
techniques to follow levels of specific IgE and IgG4
antibodies in the sera of allergic patients during
immunotherapy.
METHODS
Patients and immunotherapy
Twelve children, who consulted a pediatric clinic periodi-
cally for treatment of bronchial asthma and had not
received immunotherapy previously, were chosen to partici-
pate in the study. At the beginning of immunotherapy, their
ages were ranged from 5 to 12 years (mean 7.5 years).
RAST scores to Dermatophagoides species were 4 or 5.
Sera were taken on the first day of injection and at 6, 12,
18 and 24 months after starting immunotherapy.
House dust extract for injection was dispatched by Torii
Co. (Tokyo, Japan). The first dose of injection was 0.1 mL
at a dilution of 10-6. Injections were repeated once a
week and the dose of house dust extract was increased;
for example, 0.1, 0.2, 0.4, 0.7 and 1.0 mL at a dilution
of 10-6, 0.1, 0.2 .,. 1.0 mL at a dilution of 10-5 and so
on. By the sixth month, the amount of injection reached
0.4 mL at a dilution of 10-1• This final dose was injected
every other week as a maintenance dose. If the skin
reaction was too severe at this dose, the amount or
concentration of the extract for injection was reduced.
Preparation of mite extract for immunoblot
analyses
Dermatophagoides farinae was cultured according to
the method of Sasa et 01. 17 and the extract was prepared
according to previously described methods;" Briefly, 1 g
cultured medium containing approximately 20 000
mites was mixed in 10 mL of 0.02 rnol/L Tris-HCI buffer
(pH 7.6), homogenized with a Teflon-glass homoge-
nizer and centrifuged at 3000 9 for 20 min. The
supernatant was used as a crude mite extract. Protein
concentration was determined with a protein assay kit
(Protein Assay Kit I; Bio-Rad, Hercules, CA, USA) using
bovine serum globulin as a standard.
Immunoblotting
Crude mite extract (approximately 500 Ilg protein) was
applied to the top of a stacking gel, horizontally prepared
without combs and separated on a gradient polyacry-
lamide gel (5-15%, 16 X 16 cm) under non-reducing
and non-boiling conditions.'? Separated proteins were
transferred to a nitrocellulose sheet for immunoblotting.
To confirm the proper separation and transfer of proteins,
both edges of a 10 mm nitrocellulose sheet was cut and
stained with Coomassie Brilliant Blue. The remaining
central part of the nitrocellulose sheet was immersed in
5% skimmed milk in phosphate buffered saline (SM/PBS)
and cut into 20 strips at a width of 7 mm. Two strips were
put in a plastic bag and 2 mL patient's serum diluted 1:5
with SM/PBS containing 0.05% Tween 20 (SM/PBS/Tw)
was added. For one patient, five plastic bags were pre-
pared to incubate nitrocellulose strips and the sera at 0,
6, 12, 18 and 24 months under the same conditions. The
bags were sealed and incubated overnight at 4°C. The
next day, strips were washed with PBS/Tw five times. One
of the two strips in each bag was incubated with [1251]_
labeled anti-human IgE (Pharmacia RAST Kit; Uppsala,
Sweden) and the other strip was incubated with anti-
human IgG4 conjugated to horseradish peroxidase
(Tago, Camarillo, CA, USA; 1: 1000 diluted with
SM/PBS/Tw). Three hours later, strips were washed with
PBS/Tw four times. Strips were dried and exposed to X-ray
film (Fuji Co., Tokyo, Japan) for 7-14 days at -80°C to
detect IgE. Strips were reacted with a substrate kit (Konica
Immuno Stain HRP- 1000; Konica Co., Tokyo, Japan) to
detect IgG4•
Density scanning
The density of Der fl and Der fII bands on X-ray films or
nitrocellulose sheets was scanned by a densitometer
(Shimazu CS-9000; Shimazu Co., Kyoto, Japan) and
changes in antibody levels were traced. To test the corre-
lation between serum dilution and the density of the
bands, one patient's serum was variously diluted (1 :2.5,
1:5, 1: 10 and 1:20) and incubated with nitrocellulose
strips, on which mite antigens were separated.
Immunoblotting was performed with anti-human IgG4 as
mentioned earlier and the density of the bands was
scanned.
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Fig. 1 Autoradiography of mite antigen reacted with IgE
antibody in individual serum (a) befo re starti ng and (b) after
24 mo nths of immunotherapy. Lane 0, no n-atopic serum : lanes
1- 12, se ra of a sthmatic child ren
Reactivity of mite a ntigen to IgE and IgG.
a ntibod ies in pa tie nts' sera
Many bands appeared on X-ray fi lm when separated mite
antigen wa s reacted with patients' sera and pro bed with
[125IJ-labeled anti-human IgE (Fig. 1o]. Patterns of bands
were different in each patient. Amang many bands, the
15 kDa band (Der III) and the 24 kDa band (Der flj
RESULTS
Symptoms of bronchial a sthma
Symptoms of bronchial asthma in 12 children were
reduced or disappea red by the sixth mo nth after start ing
immunatherapy and few symptoms appeared unti l the
24th manth. It was corre lated to the develapment of IgG,
to Der III. Because we did not prepare contro l grau ps,
such as a group of placebo -injected patients or a graup
o f pa tients receiving medication only, we do not know
how much immunotherapy contributed to the reduction
of asthmatic symptoms. The RAST scores to hause dust
and D. larinae in the sera of 12 children were maintained
at 4 or 5 unti l the 24th manth.
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Fig . 2 Nitrocellulose shee ts with ba nds of mite a ntigens reacted
with IgG 4antibody in individual serum (0) before starting and (b)
after 24 months of immu notherapy. Lane 0 , non-atopic serum:
lanes 1- 12 , sera of a sthmatic children. IgG 4 a ntibodies to Der fI
increased in three of 12 cases (nos 1, 5 an d 6; a rrows) an d those
to Der III increased in l Oaf 12 cases (nos 1, 3- 10 and 12).
Fig . 3 Correlat ion between serum concentrat ion and density
of the ba nd of Der fll reacting to IgG 4 antibody. Serum of patient
no. 9 at the 24th month was diluted (x 2.5, x S. X I 0, x 20)
and reacted with nitroce llulose sheets on which mite antigen was
se pa rated. Density of Der fII ba nd was meas ured .
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appeared frequently. In 12 patients, 11 cases reacted
with Der fII and nine cases reacted with Der fl. When pre-
immunotherapy sera and sera from the 24th month after
immunotherapy (Fig. 1c.b) were compared, the densities
of the 15 kDa (Der fII) bands did not differ in each
patient. However, IgE antibodies to higher molecular
weight antigens (e.g. 24, 29, 56, 120 and 170 kDa)
developed in several patients. Molecules of 24, 29 and
56 kDa may be major mite allergens of Der fl, fill and flV,
respectively. Possibly, these IgE antibodies were induced
by repeated injections of crude house dust extract.
Symptoms of asthma in the patients who developed IgE
antibodies to higher molecular weight antigens were con-
trolled as well as in patients who did not develop IgE
antibodies to these molecules.
Before starting immunotherapy, few bands reacted with
IgG4 antibodies (Fig. 2a). After repeated injections of
house dust extract, IgG4 antibodies to Der fl increased in
three cases (nos. 1, 5 and 6) and those to Der fII
increased in 10 of 12 (Fig. 2b). In two patients (nos. 5
and 7), IgG4 antibody to 40 kDa antigen developed after
6 months of immunotherapy and continued at similar
levels until the 24th month.
Correlation between antibody concentration
and band density
Series of diluted sera and the density of bands showed a
positive correlation (Fig. 3). This suggested that the
density of the band indicated the concentration of the
antibody to the molecule. This experiment also demon-
strated that molecules separated on a nitrocellulose sheet
were not saturated with antibodies at the concentration
used in the present study (1 :5).
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Fig.4 Changes in the density of Der fl (open symbols) and Der fII (closed symbols) bands reacting with IgE (O,e) or IgG 4 (0,.)
during immunotherapy in each patient (Pt). The dose of injection is individually drawn below. HD, house dust extract.
Changes of density in Der fl and Der fll bands
reacted with IgE or IgG4 antibodies during
immunotherapy
In almost all patients, the density of Der fII bands to IgE
antibodies changed slightly, but not significantly (Fig. 4).
The density of Der fII bands was much higher than that of
Der fl bands in all patients. Two patients (nos. 9 and 12)
showed significant decreases in IgE to Der fII and
increases in IgG4 to the molecule, suggesting that com-
petition may occur between IgE and IgG4 on the Der fII
molecule.
IgG4 antibodies to Der fl and Der fII were detected at
the sixth month. The levels increased and were stable
from the 12th to the 24th month. This suggests that
repeated injections stimulate the production of IgG4 anti-
bodies to Der fl and Der fII.
DISCUSSION
Results from previous double-blind studies using crude
mite extract and placebos for injection have supported
the efficacy of immunotheropve'' Groups injected with
mite extract showed a better clinical response than
groups injected with placebo. Antibody levels of specific
IgG to crude mite extract increased in the mite extract-
injected group but not in the placebo group. Specific IgE
levels to crude mite extract did not change in either
group. Because those studies used crude mite extract for
injection and evaluation, it was impossible to analyze
which molecule in the crude mite extract reacted with IgE
antibodies and which molecule in the extract induced IgG
antibodies in the injected patients. Protein separation
techniques resolved this problem. The western blotting
technique indicates specific molecules of antigen that
react with IgE and IgG cntibodies.P'!" Little work has
been done with western blotting to look for molecules in
the mite extract that induce IgE and IgG antibodies
during immunotherapy. We attempted to analyze
changes in IgE and IgG4 antibodies to the molecules, in
particular, Der fl and Der fII.
Injection of house dust extract to asthmatic children did
not affect the production of IgE antibodies to Der fII
during the observation period. However, IgE antibodies
to higher molecular weight antigens (e.g. 120 and 170
kDa) were induced in some cases, in whom the symptoms
of asthma were still well controlled. We believe that
repeated injections of house dust extract induced IgE
antibodies to alternative molecules, in particular high
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molecular weight antigens. These high molecular weight
molecules are thought not to be able to move from
airways to immune centers, such as lymph nodes,
because of their size. Mucocutaneous barriers prevent
these large molecules from moving out of the airways.
However, if these molecules are injected, they may be
immunogens that induce immunoglobulins, including IgE
antibody. In Japan, we use house dust extract as an
antigen for injection. It contains numerous antigens.
Thus, patients are injected with many allergens, which
may cause alternative allergic disorders. To avoid induc-
tion of alternative IgE antibodies, we would like to
recommend that a purified antigen, rather than a crude
antigen, is injected for immunotherapy.
Competition between IgE and IgG4 to Der fl or Der fII
seldom occurred in the analysis method we used in the
present study. The amount of antigen on the nitro-
cellulose sheet may be enough to bind both IgE
antibodies and competitive IgG4 antibodies. This explains
the RAST score during immunotherapy. Discs for RAST
contain much antigen and competition between IgE and
IgG4 may not occur. This is why the RAST score does not
change during immunotherapy, even though sufficient
amounts of IgG4 antibodies were induced to neutralize
allergic reactions.
An extraordinary amount of IgG antibodies is needed
to block antigen in vivo at the mucocutaneous lesion
before attaching the antigen with IgE antibodies on the
mast cell surface. Our experiments do not support this
possibility. IgG levels induced by the injections were not
sufficient to prevent mite allergens from binding to spe-
cific IgE antibodies on mast cells. However, mast cell
degranulation can be inhibited if cross-linkage of IgE
antibodies on the cell surface is inhibited by IgG anti-
bodies. If IgE antibody on a mast cell captures one
antigen molecule but a free IgG antibody attaches to the
captured molecule on another site, another IgE antibody
on the cell cannot attach the antigen molecule. As a
result, cross-linkages are not formed and degranulation
does not occur. This can occur when the amounts of IgG
and IgE antibodies are similar, if the affinity of both anti-
bodies to the antigen is identical. This likely explains the
effect of immunotherapy according to our results;
however, further study is needed to confirm this.
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